Cefazolin
- Product NDC
- 60505-6231
- 11-digit product format
- 605056231
- Labeler code
- 60505
- Product ID
- 60505-6231_10b501ca-c77f-4b3f-85df-ddf2715bfcd0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cefazolin
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Apotex Corp.
- Application
- ANDA203661
- Marketing category
- ANDA
- Marketing start
- 2022-03-18
- Substance
- CEFAZOLIN SODIUM
- Active strength
- 2 g/1
- Pharmacologic classes
- Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 4c53c44d-0495-40c1-9f02-9d772dc7a5c7 | Product name | 1 | 20250318 |
| 53d47d5d-6076-4275-8f76-06d261cff1e8 | Product name | 1 | 20231011 |
| 9afe2d9a-f7f6-416b-9ddf-b780a2810bd5 | Product name | 1 | 20230912 |
| 6e62eeca-6666-f31f-9873-48ea9ede8354 | Product name | 2 | 20190214 |
| afa25392-d76e-4453-8841-fde3a34824f1 | Product name | 2 | 20160309 |
| 53cae805-773b-4bc5-a836-3e22e250892e | Product name | 1 | 20150922 |
| 05d4c919-c877-4ec4-cb08-9fcbbbfd8c70 | Product name | 1 | 20140508 |
| 75ba2549-0297-c880-16c8-4fa502c95a9d | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60505-6231-0 | Cefazolin | 1 in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, FOR SOLUTION | 1 | 13 | |
| 60505-6231-5 | Cefazolin | 25 in 1 CARTON | INJECTION, POWDER, FOR SOLUTION | 25 | 13 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60505-6231-0 | EA - Each | 60505-6231 | 6533cda7-17d5-4947-93c1-05dc314ff1f2 | 1 | 2022-04-06 |
| 60505-6231-5 | EA - Each | 60505-6231 | 27e6f759-6db5-4c5d-91b1-330aed3468b7 | 1 | 2022-04-06 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 60505-6231 | CEFAZOLIN INJECTION, POWDER, FOR SOLUTION [APOTEX CORP.] | 12 | Current NDC, Legacy NDC, 2 package rows | 20240220_0422fe47-c372-494f-bac2-612f550b44a4.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1665050 | ceFAZolin 1 GM Injection | PSN | 0422fe47-c372-494f-bac2-612f550b44a4 | 13 |
| 1665060 | ceFAZolin 2 GM Injection | PSN | 0422fe47-c372-494f-bac2-612f550b44a4 | 13 |
| 2630753 | ceFAZolin 3 GM Injection | PSN | 0422fe47-c372-494f-bac2-612f550b44a4 | 13 |
| 1665050 | cefazolin 1000 MG Injection | SCD | 0422fe47-c372-494f-bac2-612f550b44a4 | 13 |
| 1665060 | cefazolin 2000 MG Injection | SCD | 0422fe47-c372-494f-bac2-612f550b44a4 | 13 |
| 2630753 | cefazolin 3000 MG Injection | SCD | 0422fe47-c372-494f-bac2-612f550b44a4 | 13 |
| 1665060 | cefazolin (as cefazolin sodium) 2 GM Injection | SY | 0422fe47-c372-494f-bac2-612f550b44a4 | 13 |
| 2630753 | cefazolin (as cefazolin sodium) 3 GM Injection | SY | 0422fe47-c372-494f-bac2-612f550b44a4 | 13 |
| 1665050 | cefazolin 1 GM (as cefazolin sodium) Injection | SY | 0422fe47-c372-494f-bac2-612f550b44a4 | 13 |
| 1665050 | cefazolin 1 GM Injection | SY | 0422fe47-c372-494f-bac2-612f550b44a4 | 13 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 60505-6231-0 | 60505623100 | 1 in 1 VIAL, SINGLE-DOSE | Historical | ||||
| 60505-6231-5 | 60505623105 | 25 VIAL, SINGLE-DOSE in 1 CARTON (60505-6231-5) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (60505-6231-0) | 2022-03-18 | 0000-00-00 | No | No | Current |